| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
251,510,000 |
| Market
Cap: |
136.22(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$414.13 - $543.89 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 17 |
| Guru Rank Value : 22.1 |
| Guru Occurances : 4 |
|
|
|
|
|
| |
|
Company Profile Elevance Health is an insurance holding company. Co. is a health benefits company, serving medical members through its affiliated health plans. Co. has four segments: Commercial and Specialty Business, which provides fully-insured health products, managed care services; Government Business, which includes Medicare and Medicaid businesses, its subsidiary, National Government Services, and services provided to the federal government in connection with its Federal Health Products and Services business; IngenioRx, which includes its pharmacy benefit management business; and Other, which includes Diversified Business Group, which is its integrated health services business.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
44,753 |
52,053 |
52,427 |
77,577 |
| Total Sell Value |
$23,062,766 |
$26,598,808 |
$26,775,666 |
$38,325,083 |
| Total People Sold |
4 |
6 |
7 |
8 |
| Total Sell Transactions |
5 |
8 |
10 |
15 |
| End Date |
2024-02-18 |
2023-11-17 |
2023-05-19 |
2022-05-19 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Haytaian Peter D |
EVP & President, Commercial |
• • – |
2019-11-18 |
4 |
OE |
$61.88 |
$232,793 |
D/D |
3,762 |
41,377 |
|
- |
|
| Penczek Ronald W |
SVP, Chief Accounting Officer |
• • – |
2019-11-13 |
4 |
S |
$287.00 |
$234,192 |
D/D |
(816) |
1,938 |
|
- |
|
| Penczek Ronald W |
SVP, Chief Accounting Officer |
• • – |
2019-11-13 |
4 |
OE |
$232.04 |
$189,345 |
D/D |
816 |
2,754 |
|
- |
|
| Penczek Ronald W |
SVP, Chief Accounting Officer |
• • – |
2019-11-12 |
4 |
S |
$282.00 |
$100,674 |
D/D |
(357) |
1,938 |
|
- |
|
| Penczek Ronald W |
SVP, Chief Accounting Officer |
• • – |
2019-11-12 |
4 |
OE |
$166.97 |
$59,608 |
D/D |
357 |
2,295 |
|
- |
|
| Haytaian Peter D |
EVP & President, Commercial |
• • – |
2019-10-28 |
4 |
S |
$269.08 |
$2,584,128 |
D/D |
(9,586) |
37,615 |
|
- |
|
| Mccarthy Gloria M |
EVP & Chief Administrative Off |
• • – |
2019-10-03 |
4 |
D |
$238.23 |
$146,988 |
D/D |
(617) |
38,126 |
|
- |
|
| Schneider Ryan M. |
Director |
• • – |
2019-10-01 |
4 |
A |
$0.00 |
$0 |
D/D |
522 |
522 |
|
- |
|
| Patel Prakash R |
EVP & President, DBG |
• • – |
2019-09-04 |
4 |
D |
$254.23 |
$27,711 |
D/D |
(109) |
3,109 |
|
- |
|
| Hill Julie A |
Director |
• • – |
2019-07-26 |
4 |
S |
$295.00 |
$488,520 |
D/D |
(1,656) |
32,924 |
|
- |
|
| Dixon Robert L Jr |
Director |
• • – |
2019-07-26 |
4 |
S |
$294.11 |
$152,937 |
D/D |
(520) |
9,971 |
|
- |
|
| Norwood Felicia F |
Exec VP & President, GBD |
• • – |
2019-07-02 |
4 |
D |
$280.66 |
$49,396 |
D/D |
(176) |
3,843 |
|
- |
|
| Zielinski Thomas C |
EVP & General Counsel |
• • – |
2019-06-11 |
4 |
S |
$283.92 |
$2,505,878 |
D/D |
(8,826) |
32,183 |
|
- |
|
| Zielinski Thomas C |
EVP & General Counsel |
• • – |
2019-06-11 |
4 |
OE |
$108.35 |
$1,419,225 |
D/D |
8,826 |
41,009 |
|
- |
|
| Gallina John E |
EVP & Chief Financial Officer |
• • – |
2019-06-03 |
4 |
D |
$276.44 |
$562,003 |
D/D |
(2,033) |
18,751 |
|
- |
|
| Penczek Ronald W |
SVP, Chief Accounting Officer |
• • – |
2019-05-30 |
4 |
S |
$279.00 |
$212,877 |
D/D |
(763) |
1,938 |
|
- |
|
| Penczek Ronald W |
SVP, Chief Accounting Officer |
• • – |
2019-05-30 |
4 |
OE |
$131.80 |
$113,119 |
D/D |
763 |
2,701 |
|
- |
|
| Peru Ramiro G |
Director |
• • – |
2019-05-21 |
4 |
AS |
$275.00 |
$455,400 |
D/D |
(1,656) |
11,173 |
|
- |
|
| Neri Antonio F |
Director |
• • – |
2019-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
753 |
1,847 |
|
- |
|
| Hill Julie A |
Director |
• • – |
2019-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
753 |
34,580 |
|
- |
|
| Tallett Elizebeth E |
Director |
• • – |
2019-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
753 |
7,814 |
|
- |
|
| Peru Ramiro G |
Director |
• • – |
2019-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
753 |
12,829 |
|
- |
|
| Jallal Bahija |
Director |
• • – |
2019-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
753 |
1,710 |
|
- |
|
| Hay Lewis III |
Director |
• • – |
2019-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
753 |
8,429 |
|
- |
|
| Clark R Kerry |
Director |
• • – |
2019-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
753 |
6,562 |
|
- |
|
1950 Records found
|
|
Page 11 of 78 |
|
|
6.09 (1.11%) 
